MADISON, Wis., October 24, 2022 – Cellular Logistics has been awarded a $337,000 SBIR grant from the National Institutes of Health to further evaluate the functional immune and angiogenic (blood vessel growth) responses of the company's Cardiac Fibroblast Matrix product, CFX™ Solus, for the treatment...
New study identifies protein essential to form stem cell-derived human heart cells...
MADISON, WI, May 16, 2022 – Cellular Logistics, a Madison, Wisconsin company that is creating a new way to restore heart function and help patients with heart damage is launching a new financing round to advance its product, Tandem™, to the next stage of product development, and moving...
MADISON, WI, May 10, 2022 – Cellular Logistics, a Madison-area company that is creating a new way to restore heart function and help patients with heart damage has been chosen to present at the Midwest Growth Capital Symposium (MGCS) being held on May 17-18, 2022. 2022...
Cellular Logistics Receives Commercialization Funding...
MADISON, WI, November 23, 2021 – Cellular Logistics, a Madison-area company that is creating a new way to restore heart function and help patients with heart damage announces promising early data using its Tandem™ biomatrix technology. Investigators at the University of Wisconsin-Madison, led by Drs....
Cellular Logistics Selected to Pitch at the Wisconsin Early Stage Symposium...
Early-stage biotech startups find common ground at Forward BIOLABS...
MADISON, Wis., July 20, 2021 – Cellular Logistics, a Madison-area company that hopes to create new ways to restore heart function and help patients with heart damage, has appointed Philippe Marchand as a new member of their Scientific Advisory Board (SAB). Mr. Marchand, a biosystems engineer, brings 25 years...
Dr. Eric Schmuck & Cellular Logistics Awarded SEED Grant ...
